UBS AM’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Sell |
17,403
-2,574
| -13% | -$243K | ﹤0.01% | 2230 |
|
|
2025
Q1 | $2.37M | Buy |
19,977
+685
| +4% | +$81.3K | ﹤0.01% | 1909 |
|
|
2024
Q4 | $2.54M | Buy |
19,292
+9,189
| +91% | +$1.21M | ﹤0.01% | 1927 |
|
|
2024
Q3 | $1.31M | Buy |
10,103
+1,708
| +20% | +$222K | ﹤0.01% | 2255 |
|
|
2024
Q2 | $728K | Buy |
8,395
+6,080
| +263% | +$528K | ﹤0.01% | 2515 |
|
|
2024
Q1 | $254K | Hold |
2,315
| – | – | ﹤0.01% | 2430 |
|
|
2023
Q4 | $243K | Hold |
2,315
| – | – | ﹤0.01% | 2464 |
|
|
2023
Q3 | $243K | Sell |
2,315
-1,526
| -40% | -$160K | ﹤0.01% | 2474 |
|
|
2023
Q2 | $671K | Hold |
3,841
| – | – | ﹤0.01% | 2196 |
|
|
2023
Q1 | $671K | Hold |
3,841
| – | – | ﹤0.01% | 2196 |
|
|
2022
Q4 | $638K | Buy |
3,841
+632
| +20% | +$105K | ﹤0.01% | 2074 |
|
|
2022
Q3 | $452K | Hold |
3,209
| – | – | ﹤0.01% | 2378 |
|
|
2022
Q2 | $654K | Hold |
3,209
| – | – | ﹤0.01% | 2177 |
|
|
2022
Q1 | $818K | Hold |
3,209
| – | – | ﹤0.01% | 2246 |
|
|
2021
Q4 | $1.05M | Hold |
3,209
| – | – | ﹤0.01% | 2191 |
|
|
2021
Q3 | $970K | Hold |
3,209
| – | – | ﹤0.01% | 2182 |
|
|
2021
Q2 | $870K | Sell |
3,209
-1,663
| -34% | -$451K | ﹤0.01% | 2280 |
|
|
2021
Q1 | $1.19M | Hold |
4,872
| – | – | ﹤0.01% | 2005 |
|
|
2020
Q4 | $1.4M | Hold |
4,872
| – | – | ﹤0.01% | 1828 |
|
|
2020
Q3 | $1.24M | Buy |
4,872
+205
| +4% | +$52.2K | ﹤0.01% | 1756 |
|
|
2020
Q2 | $1.01M | Buy |
4,667
+1,482
| +47% | +$321K | ﹤0.01% | 1800 |
|
|
2020
Q1 | $720K | Buy |
3,185
+17
| +0.5% | +$3.84K | ﹤0.01% | 1823 |
|
|
2019
Q4 | $790K | Buy |
3,168
+849
| +37% | +$212K | ﹤0.01% | 2038 |
|
|
2019
Q3 | $551K | Buy |
2,319
+1,226
| +112% | +$292K | ﹤0.01% | 2245 |
|
|
2019
Q2 | $267K | Buy |
+1,093
| New | +$267K | ﹤0.01% | 2449 |
|